bat365官网登录入口» 学术信息

学术信息

(2.28)【院长论坛】Depot-specific targeting of fat

bat365官网登录入口


院长论坛


报告题目:Depot-specific targeting of fat


报  告 人:强力, Ph.D.

                Associate Professor with Tenure

哥伦比亚大学


时      间:2023年2月28日(星期二)下午15:30


地      点医学部科技楼西楼一层大会议室


主  持 人: 杨宝学 副院长


报告人简介:

强力博士,哥伦比亚大学病理学与细胞生物学系、Naomi Berrie糖尿病中心终身副教授。长期专注于肥胖和衰老的病理生理学中脂肪重塑的机制研究。迄今为止在《Cell》、《Cell Metabolism》、《JCI》、《ACS Nano》、《J. of Hepatology》、《Nature Nanotechnology》、《Biomaterials》、《Diabetes》、《Advanced Sciences》等国际主流刊物上发表了一系列高水平SCI论文。研究成果“白色脂肪棕色重塑”被评选为2022年度代谢领域十大进展之一,开创了针对局部肥胖的脂肪重塑治疗。发现了选择性激活抗糖尿病药物靶点PPARg,为开发安全性更高的下一代胰岛素增敏剂铺平道路。强力博士2001年毕业于北京大学,2007年获得波士顿大学医学院博士学位,曾获NIH职业发展奖和Kern Lipid会议早期研究员奖。

Dr. Qiang is an Associate Professor with Tenure in the Department of Pathology and Cell Biology and the Naomi Berrie Diabetes Center at Columbia University. His laboratory focuses on the mechanisms of adipose remodeling in the pathophysiology of obesity and aging. He and his team have published in Cell, Cell Metabolism, JCI, ACS Nano, J. of Hepatology, Nature Nanotechnology, Biomaterials, Diabetes, Advanced Sciences, etc. His finding of brown remodeling of white fat was among the year’s top ten notable advances in metabolism. He pioneers depot-specific targeting of fat for local obesity treatment. His findings on the selective activation of anti-diabetic drug target PPARg pave the way for the development of next-generation insulin sensitizers with improved safety. Dr. Qiang has received the NIH career development award with a perfect score and Kern Lipid Conference Early Investigator Award. He graduated from Peking University in 2001 and received his doctoral degree from Boston University School of Medicine in 2007.


欢迎师生参加!